0001437749-23-015634.txt : 20230524
0001437749-23-015634.hdr.sgml : 20230524
20230524060503
ACCESSION NUMBER: 0001437749-23-015634
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230519
FILED AS OF DATE: 20230524
DATE AS OF CHANGE: 20230524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Osborne Mary Louise
CENTRAL INDEX KEY: 0001878938
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31932
FILM NUMBER: 23950495
MAIL ADDRESS:
STREET 1: 2200 PASEO VERDE PARKWAY
STREET 2: SUITE 280
CITY: HENDERSON
STATE: NV
ZIP: 89052
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ontrak, Inc.
CENTRAL INDEX KEY: 0001136174
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 880464853
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 PASEO VERDE PARKWAY
STREET 2: SUITE 280
CITY: HENDERSON
STATE: NV
ZIP: 89052
BUSINESS PHONE: 310 444 4300
MAIL ADDRESS:
STREET 1: 2200 PASEO VERDE PARKWAY
STREET 2: SUITE 280
CITY: HENDERSON
STATE: NV
ZIP: 89052
FORMER COMPANY:
FORMER CONFORMED NAME: CATASYS, INC.
DATE OF NAME CHANGE: 20110316
FORMER COMPANY:
FORMER CONFORMED NAME: HYTHIAM, INC.
DATE OF NAME CHANGE: 20101029
FORMER COMPANY:
FORMER CONFORMED NAME: HYTHIAM INC
DATE OF NAME CHANGE: 20031003
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-05-19
0001136174
Ontrak, Inc.
OTRK
0001878938
Osborne Mary Louise
2200 PASEO VERDE PARKWAY, SUITE 280
HENDERSON
NV
89052
1
Chief Commercial Officer
0
Option (right to buy)
0.41
2023-05-19
4
A
0
100000
A
2031-08-30
Common Stock
100000
100000
D
Option (right to buy)
1.74
2023-05-19
4
D
0
100000
D
2031-08-30
Common Stock
100000
0
D
Option (right to buy)
0.41
2023-05-19
4
A
0
27750
A
2029-04-12
Common Stock
27750
27750
D
Option (right to buy)
1.73
2023-05-19
4
D
0
27750
D
2029-04-12
Common Stock
27750
0
D
25,000 of these shares vested on August 30, 2022 and the remaining shares vest equally over the following 36 months, such that all shares shall be vested on August 30, 2025. There was no change to the vesting schedule in connection with the repricing transaction on May 19, 2023.
The reporting person agreed to the repricing of options originally granted to her on August 30, 2021 and April 12, 2022.
6,938 of these shares vested on April 12, 2023 and the remaining shares vest equally each quarter thereafter over the following three years, such that all shares shall be vested on April 12, 2026. There was no change to the vesting schedule in connection with the repricing transaction on May 19, 2023.
/s/ Mary Louise Osborne
2023-05-23